Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.49 - $1.2 $94,610 - $231,699
-193,083 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.85 - $2.4 $129,654 - $366,084
152,535 Added 376.18%
193,083 $220,000
Q4 2021

Feb 14, 2022

BUY
$1.86 - $3.36 $10,233 - $18,486
5,502 Added 15.7%
40,548 $92,000
Q2 2021

Aug 16, 2021

BUY
$2.66 - $3.47 $93,222 - $121,609
35,046 New
35,046 $105,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.